Kristopher Hanson
General Counsel at MapLight Therapeutics, Inc. (MPLT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 18SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 16,509137,044 held (−11%) | $11.67 | $193K | -24.3% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 2,147160,184 held (−1%) | $36.00 | $77K | -75.5% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 5,103155,081 held (−3%) | $36.99 | $189K | -76.1% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 10155,071 held (−0%) | $37.54 | $375 | -76.5% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 4,776150,295 held (−3%) | $36.45 | $174K | -75.8% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 3,331146,964 held (−2%) | $37.26 | $124K | -76.3% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 11146,953 held (−0%) | $37.96 | $418 | -76.7% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 1,130145,823 held (−1%) | $37.90 | $43K | -76.7% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 284175,964 held (−0%) | $27.61 | $8K | -68.0% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 846175,118 held (−0%) | $28.70 | $24K | -69.2% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 6,979168,139 held (−4%) | $30.04 | $210K | -70.6% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 5,808162,331 held (−3%) | $30.56 | $177K | -71.1% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 9,030181,135 held (−5%) | $27.50 | $248K | -67.9% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 3,908177,227 held (−2%) | $28.29 | $111K | -68.8% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 296176,931 held (−0%) | $29.56 | $9K | -70.1% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 683176,248 held (−0%) | $30.08 | $21K | -70.6% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 1,529190,463 held (−1%) | $26.80 | $41K | -67.1% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 73190,390 held (−0%) | $27.01 | $2K | -67.3% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 225190,165 held (−0%) | $27.49 | $6K | -67.9% |
- Sell
General Counsel Kristopher Hanson sold $193K of MPLT at $11.67 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Kristopher Hanson sold $8K of MPLT at $27.61 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Kristopher Hanson sold $24K of MPLT at $28.70 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Kristopher Hanson sold $210K of MPLT at $30.04 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Kristopher Hanson sold $177K of MPLT at $30.56 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Kristopher Hanson sold $248K of MPLT at $27.50 — pre-scheduled 10b5-1 plan sale.